SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015961
Filing Date
2021-11-15
Accepted
2021-11-15 16:03:25
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmbr-20210930x10q.htm   iXBRL 10-Q 1758270
2 EX-31.1 tmbr-20210930xex31d1.htm EX-31.1 17827
3 EX-31.2 tmbr-20210930xex31d2.htm EX-31.2 16096
4 EX-32.1 tmbr-20210930xex32d1.htm EX-32.1 7882
5 EX-32.2 tmbr-20210930xex32d2.htm EX-32.2 9389
  Complete submission text file 0001558370-21-015961.txt   7491367

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmbr-20210930.xsd EX-101.SCH 60794
7 EX-101.CAL tmbr-20210930_cal.xml EX-101.CAL 55746
8 EX-101.DEF tmbr-20210930_def.xml EX-101.DEF 267178
9 EX-101.LAB tmbr-20210930_lab.xml EX-101.LAB 491501
10 EX-101.PRE tmbr-20210930_pre.xml EX-101.PRE 401906
11 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20210930x10q_htm.xml XML 1365866
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 211410205
SIC: 2834 Pharmaceutical Preparations